Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$2.4M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 4 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 9 most recent Form 4 transactions.
| May 21 | NBIX | Neurocrine Biosciences INC | MEXER | 3,318 | — | — | +9.6% | Open the original filing on SEC.gov |
| May 15 | NBIX | Neurocrine Biosciences INC | MEXER◷◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| May 15 | NBIX | Neurocrine Biosciences INC | SSELL◷ | 15,000 | $157.65 | $2.4M | -30.3% | Open the original filing on SEC.gov |
| May 15 | NBIX | Neurocrine Biosciences INC | MEXER◷ | 15,000 | $47.89 | $718.4K | +43.5% | Open the original filing on SEC.gov |
| Mar 2 | ALKS | Alkermes plc. | AGRANT◆ | 88,843 | — | — | — | Open the original filing on SEC.gov |
| Feb 5 | ALKS | Alkermes plc. | FTAX | 62,230 | $33.55 | $2.1M | -4.3% | Open the original filing on SEC.gov |
| Feb 5 | ALKS | Alkermes plc. | AGRANT | 149,580 | — | — | +11.6% | Open the original filing on SEC.gov |